X

Read Important Information on Helixate® FS, Antihemophilic Factor (Recombinant)

Read Important Information on Helixate® FS, Antihemophilic Factor (Recombinant)

Protection Delivered With a Low Number of Factor Units

Adjust regimen based on patient response

The recommended starting regimen (administered 2x or 3x weekly) is

  • 20-50 IU/kg for patients ≥12 years
  • 30-50 IU/kg for patients <12 years

Patients <12 years may require more frequent or higher dose

In AFSTYLA clinical trials, median doses were:

  • 2x weekly
    • 35 IU/kg for patients of all ages
  • 3x weekly
    • 30 IU/kg for patients ≥12 years
    • 32 IU/kg for patients <12 years
2x weekly
3x weekly
Calculate
IU
per dose
IU
per 30-day prescription

Note: For healthcare professional use only. Use of this tool is not a substitute for the clinical expertise of a licensed medical professional.

You are now leaving the current website.

Do you want to continue?

No Yes